CN Patent

CN109381440A — 一种艾乐替尼组合物

Assigned to Weihai Guanbiao Information Technology Co Ltd · Expires 2019-02-26 · 7y expired

What this patent protects

本发明涉及一种艾乐替尼口服药物，属于药物制剂技术领域。本发明所述艾乐替尼组合物，每千个单位剂量中，含有D 90 为36‑55微米的艾乐替尼150g，吐温80 4‑8g，气相二氧化硅8‑26g，硫酸钙2‑8g，羟丙基纤维素18‑32g，无水乳糖20‑46g，乙二胺四乙酸二钠4‑8g，硬脂酸镁1.0‑1.5g。本发明技术方案通过几种组分的合理配伍，一是提高了主药的溶出，二是气相二氧化硅、硫酸钙、乙二胺四乙酸二钠的联和作用，提高了储存过程中的抗吸湿性能。

USPTO Abstract

本发明涉及一种艾乐替尼口服药物，属于药物制剂技术领域。本发明所述艾乐替尼组合物，每千个单位剂量中，含有D 90 为36‑55微米的艾乐替尼150g，吐温80 4‑8g，气相二氧化硅8‑26g，硫酸钙2‑8g，羟丙基纤维素18‑32g，无水乳糖20‑46g，乙二胺四乙酸二钠4‑8g，硬脂酸镁1.0‑1.5g。本发明技术方案通过几种组分的合理配伍，一是提高了主药的溶出，二是气相二氧化硅、硫酸钙、乙二胺四乙酸二钠的联和作用，提高了储存过程中的抗吸湿性能。

Drugs covered by this patent

Patent Metadata

Patent number
CN109381440A
Jurisdiction
CN
Classification
—
Expires
2019-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Weihai Guanbiao Information Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.